Do not be misled by members of the Activist Group that are attempting to take control of AIM’s Board for the third year in a row.
Electing the Activist Group's nominees could severely disrupt our forward momentum, give them access to AIM's capital and destroy the chances of near-term value creation for shareholders.
AIM is building on substantial momentum in recent years, including with our lead drug candidate, Ampligen, in areas with significant unmet needs – especially in the high-value pancreatic cancer space. The Company expects to achieve additional clinical milestones during the remainder of 2024.
The Board has the deep knowledge of the Company and its drug candidates to continue advancing the clinical and operational execution of AIM's pipeline.
Lead candidate Ampligen continues to fuel a broad pipeline in multiple high-value therapeutic indications, with a growing body of positive safety and efficacy data.
Ensuring ability to enable continued clinical progress and operations to bring Ampligen to market and help patients in need.
Several individuals in an “Activist Group” with concerning backgrounds have been engaged in a multi-year effort to disrupt AIM’s business and take over the Board.
With no proposed CEO candidate or operational plan, we believe the Activist Group's self-interested agenda will put the Company's progress at serious risk.
Following failed nomination efforts in 2022 and 2023, members of the Activist Group have once again returned to take control of the Board by nominating a slate of four directors to replace the entire Board.
The Activist Group, which is comprised of interconnected individuals and includes individuals who have close ties to convicted felons, has employed nefarious tactics to try to gain control of the Board since 2022.
AIM remains committed to protecting the best interests of all shareholders.
Anonymously submit your views or concerns using the below form. Note that your personal information will not be saved.
Our Commitment to Privacy
The sponsor of this website, www.SafeguardAIM.com, is AIM ImmunoTech Inc. (the “Sponsor”). We respect and value your privacy. This Privacy Policy is designed to assist you in understanding what information is collected from or about you through this website and how we use and safeguard that information, as well as to assist you in making informed decisions when using the website.
The core of our Privacy Policy is this:
We want you to feel safe and comfortable when you use the website, and we are dedicated to developing and upholding high standards for protecting your privacy. You should read and familiarize yourself with this Privacy Policy and with our Terms and Conditions. If you do not agree with our policies and practices, your choice is not to use this website. By accessing or using this website, you agree to this Privacy Policy.
WHAT INFORMATION DO WE COLLECT?
Our website does not ask you to provide any personally identifiable information. Instead, this website only collects “clickstream data” that provides information about the type of device and browser you are using, and the website from which you linked to our website. We may collect this data via “cookies” or other, similar technologies. For more information about cookies, visit http://www.allaboutcookies.org/.
We may use this data in an aggregate, non-personally identifiable way to help us analyze and answer questions like how much time visitors spend on each page of this website, how visitors navigate throughout this website and how we may tailor our web pages to better meet the needs of visitors. This information will be used to improve this website.
DO WE DISCLOSE INFORMATION TO OUTSIDE PARTIES?
We may provide aggregate information to our affiliates or reputable third parties for the purposes described herein.
WHAT ABOUT LEGALLY COMPELLED DISCLOSURE OF INFORMATION?
We may disclose information when we, in good faith, believe that the law requires it or for the protection of our legal rights.
WHAT ABOUT OTHER WEBSITES LINKED TO OUR SITE?
We are not responsible for the practices employed by websites linked to or from this website nor the information or content contained therein. Often links to other websites are provided solely as pointers to information on topics that may be useful to the users of our website. Please remember that your browsing and interaction on any other website, including websites which have a link on this website, is subject to that website’s own rules and policies. Please review those rules and policies.
CHANGES TO THIS POLICY
We reserve the right to make changes to this Privacy Policy from time to time. Revisions will be posted on this page. We suggest you check this page occasionally for updates. Any continued use of this website after the effective date of any modification to the Privacy Policy will be deemed to be an agreement to the modified terms.
PRIVACY OF CHILDREN
This website is not intended for children under 13 years of age. No one under age 13 may provide any personal information to or on this website. We do not knowingly collect personal information from children under 13. If you are under 13, do not use or provide any information on this website or on or through any of its features/register on this website, use any of the interactive or public comment features of this website, or provide any information about yourself to us, including your name, address, telephone number, email address, or any screen name or user name you may use. If we learn we have collected or received personal information from a child under 13 without verification of parental consent, we will delete that information. If you believe we might have any information from or about a child under 13, please contact us at aim@longacresquare.com.
CONTACTING US
If you have any questions about this Privacy Policy, the practices of this website, or your dealings with this website, you can contact aim@longacresquare.com.
Persons who access the information made available by AIM ImmunoTech Inc. (together with its affiliates, “AIM” or “we” or “us”) via this website (this “website”) agree to the following:
While the material on this website is often about investments, none of it is offered as investment advice. For members of the public, this means that neither the receipt nor the distribution of information through this website constitutes the formation of an investment advisory relationship, or any similar client relationship. The materials on this website are for informational purposes only and may not be relied on by any person for any purpose and are not, and should not be construed as investment, financial, legal, tax or other advice, recommendation or research.
This website contains hyperlinks to websites operated by AIM and other parties. AIM does not control the content or accuracy of information on third-party websites and does not otherwise endorse the material placed on such sites.
All information and content on this website is furnished “AS IS,” without warranty of any kind, express or implied. AIM will not assume any liability for any loss or damage of any kind arising, whether direct or indirect, caused by the use of any part of the information provided. AIM and its licensors do not warrant that the content is accurate, reliable or correct; that the website will be available at any particular time or location; that any defects or errors will be corrected; that unauthorized access to or misappropriation of the content will not occur; or that the content is free of viruses or other harmful components. Your use of this website is solely at your risk.
The entire website is subject to copyright with all rights reserved. No permission is granted to copy, distribute, modify, post or frame any text, graphics, video, audio, software code, or user interface design or logos. The information contained herein shall not be published, rewritten for broadcast or publication or redistributed in any medium without prior written permission from AIM.